Circadian disruption, shift work and the risk of cancer: A summary of the evidence and studies in Seattle

Cancer Causes and Control

Volumn 17, Issue 4, 2006, Pages 539-545

  Davis, Scott ^a,b,c   Mirick, Dana K ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Breast cancer; Circadian rhythm; Electromagnetic fields; Environmental carcinogens; Light; Melatonin; Pineal; Shift work

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; ANDROGEN; ANDROSTANEDIOL; ANDROSTANOLONE; ANDROSTERONE; CORTISONE; ESTRADIOL; ESTROGEN; ESTRONE; ETIOCHOLANONE; FOLLITROPIN; GLOBULIN; GONADOTROPIN; HYDROCORTISONE; LUTEINIZING HORMONE; MELATONIN; MELATONIN DERIVATIVE; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE;

AIRPLANE PILOT; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CARDIOVASCULAR DISEASE; CATERING SERVICE; CIRCADIAN RHYTHM; COMPARATIVE STUDY; DISEASE ASSOCIATION; ESTROGEN URINE LEVEL; EXPERIMENTAL MOUSE; HORMONE ACTION; HORMONE DETERMINATION; HORMONE URINE LEVEL; HUMAN; HYDROCORTISONE URINE LEVEL; LIGHT EXPOSURE; MAGNETIC FIELD; NIGHT WORK; NONHUMAN; OCCUPATIONAL CANCER; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; POLICE; PRIORITY JOURNAL; PROSTATE CANCER; REPRODUCTIVE HEALTH; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; STROKE; UNITED STATES; URINALYSIS; WORK SCHEDULE;

ANIMALS; BREAST NEOPLASMS; CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; ELECTROMAGNETIC FIELDS; HUMANS; MELATONIN; NEOPLASMS; RISK FACTORS; WORK SCHEDULE TOLERANCE;

EID: 33645500010     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-005-9010-9     Document Type: Review

References (83)

1. Angersbach D, Knauth P, Loskant H, et al. (1980) A retrospective cohort study comparing complaints and diseases in day and shift workers. Intern Arch Occup Environ Health 45:127-140
2. Colligan MJ, Frock IJ, Tasto D (1980) Shift work - the incidence of medication use and physical complaints as a function of shift. Occupational and Health Symposia - 1978. Washington, DC: US Dept of Health, Education and Welfare. (NIOSH Publication 80-105)
3. Minors DS, Scott AR, Waterhouse JM (1986) Circadian arrhythmia: shiftwork, travel and health. J Soc Occup Med 36:39-44
4. Knutsson A, Hallquist J, Reuterwall C, et al. (1999) Shift work and myocardial infarction: a case-control study. Occup Environ Med 56:46-50
5. Steenland K, Fine L (1996) Shift work, shift change, and risk of death from heart disease at work. Am J Ind Med 29:278-281
6. Tuchsen F (1993) Working hours and ischaemic heart disease in Danish men: a 4-year cohort study of hospitalization. Int J Epidemiol 22:215-221
7. Knutsson A, Akerstedt T, Jonsson BG, et al. (1986) Increased risk of ischaemic heart disease in shift workers. Lancet 2:89-92
8. Kawachi I, Colditz GA, Stampfer MJ, et al. (1995) Prospective study of shift work and risk of coronary heart disease in women. Circulation 92:3178-3182
9. Alfredsson L, Karasek R, Theorell T (1982) Myocardial infarction risk and psychosocial work environment: an analysis of the male Swedish working force. Soc Sci Med 16:463-467
10. Tenkanen L, Sjoblom T, Kalimo R, et al. (1997) Shift work, occupation and coronary heart disease over 6 years of follow-up in the Helsinki Heart Study. Scand J Work Environ Health 23:257-265
11. Mammalle N, Laumon E, Lazar P (1984) Prematurity and occupational activity during pregnancy. Am J Epidemiol 119:309
12. McDonald AD, McDonald JC, Armstrong B, et al. (1988) Prematurity and work in pregnancy. Br J Ind Med 45:56-62
13. Nurminen T (1989) Shift work, fetal development and course of pregnancy. Scand J Work Environ Health 15:395-403
14. Arendt J, Deacon S (1997) Treatment of circadian rhythm disorders-melatonin. Chronobiol Int 14:185-204
15. Axelsson G, Rylander R, Molin I (1989) Outcome of pregnancy in relation to irregular and inconvenient work schedules. Br J Ind Med 46:393-398
16. Xu X, Ding M, Li B, Christiani DC (1994) Association of rotating shiftwork with preterm births and low birth weight among never smoking women textile workers in China. Occup Environ Med 51:470-474
17. McDonald AD, McDonald JC, Armstrong B, et al. (1988) Fetal death and work in pregnancy. Br J Ind Med 45:148-157
18. Axelsson G, Ahlborg G Jr, Bodin L (1996) Shift work, nitrous oxide exposure, and spontaneous abortion among Swedish midwives. Occup Environ Med 53:374-378
19. Axelsson G, Lutz C, Rylander R (1984) Exposure to solvents and outcome of pregnancy in university laboratory employees. Br J Ind Med 41:305-312
20. Hemminki K, Kyyronen P, Lindbohm ML (1985) Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome. J Epidemiol Community Health 39:141-147
21. Uehata T, Sasakawa N (1982) The fatigue and maternity disturbances of night workwomen. J Hum Ergol (Tokyo) 11:465-474
22. Ahlborg G Jr, Axelsson G, Bodin L (1996) Shift work, nitrous oxide exposure and subfertility among Swedish midwives. Int J Epidemiol 25:783-790
23. Bisanti L, Olsen J, Basso O, et al. (1996) Shift work and subfecundity: a European multicenter study. J Occup Environ Med 38:352-358
24. Hansen J (2001) Increased breast cancer risk among women who work predominantly at night. Epidemiology 12:74-77
25. Davis S, Mirick DK, Stevens RG (2001) Night shift work, light at night, and the risk of breast cancer. J Natl Cancer Inst 93:1557-1562
26. Schernhammer ES, Laden F, Speizer FE, et al. (2001) Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J Natl Cancer Inst 93:1563-1568
27. Schernhammer ES, Laden F, Speizer FE, et al. (2003) Night-Shift Work and Risk of Colorectal Cancer in the Nurses' Health Study. J Natl Cancer Inst 95:825-828
28. Pukkala E, Auvinen H, Wahlberg G (1995) Incidence of cancer among Finnish airline cabin attendants. BMJ 311:649-652
29. Rafnsson V, Tulinius H, Jonasson JG, et al. (2001) Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 12:95-101
30. Tynes T, Hannevik M, Andersen A, et al. (1996) Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 7:197-204
31. Band PR, Spinelli JJ, Ng VTY, et al. (1990) Mortality and cancer incidence in a cohort of commercial airline pilots. Aviat Space Environ Med 61:299-302
32. Irvine D, Davies DM (1992) The mortality of British Airways pilots 1966-89:a proportional mortality study. Aviat Space Environ Med 63:276-279
33. Band PR, Le ND, Fang R, et al. (1996) Cohort study of Air Canada pilots: mortality, cancer incidence, and leukemia risk. Am J Epidemiol 143:137-143
34. Krstev S, Baris D, Stewart PA, et al. (1998) Risk for prostate cancer by occupation and industry: a 24-state death certificate study. Am J Ind Med 34:413-420
35. Irvine D, Davies DM (1999) British Airways flightdeck mortality study, 1950-92. Aviat Space Environ Med 70:548-555
36. Rfnassan V, Hrafnkelsson J, Tulinius H (2000) Incidence of cancer among commercial airline pilots. Occup Environ Med 57:175-179
37. Pukkala E, Aspholm R, Auvinen A, et al. (2002) Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study. BMJ 325:567-569
38. Pukkala E, Aspholm R, Auvinen A, et al. (2003) Cancer incidence among 10,211 airline pilots: a Nordic study. Aviat Space Environ Med 74:699-706
39. Krstev S, Baris D, Stewart P, et al. (1998) Occupational risk factors and prostate cancer in U.S. blacks and whites. Am J Ind Med 34:421-430
40. Demers PA, Checkoway H, Vaughan TL, et al. (1994) Cancer incidence among firefighters in Seattle and Tacoma, Washington (United States). Cancer Causes Control 5:129-135
41. Hill SM, Blask DE (1988) Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 48:6121-6126
42. Cos S, Fernandez F, Sanchez-Barcelo EJ (1996) Melatonin inhibits DNA synthesis in MCF-7 human breast cancer cells in vitro. Life Sci 58:2447-2453
43. Cos S, Fernandez R, Guezmes A, et al. (1998) Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.Cancer Res 58:4383-4390
44. Cos S, Mediavilla MD, Fernandez R, et al. (2002) Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro? J Pineal Res 32:90-96
45. Mediavilla MD, Cos S, Sanchez-Barcelo EJ (1999) Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sci 65:415-420
46. Siu SW, Lau KW, Tam PC, et al. (2002) Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Prostate 52:106-122
47. Rimler A, Lupwitz Z, Zisapel N (2002) Differential regulation by melatonin of cell growth and androgen receptor binding to the androgen response element in prostate cancer cells. Neuroendocrinol Lett 23:45-49
48. Marelli MM, Limonta P, Maggi R, et al. (2000) Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells. Prostate 45:238-244
49. Xi SC, Tam PC, Brown GM, et al. (2000) Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells. J Pineal Res 29:172-183
50. Moretti RM, Marelli MM, Maggi R, et al. (2000) Anti-proliferative action of melatonin on human prostate cancer LNCaP cells. Oncol Rep 7:347-351
51. Philo R, Berkowitz AS (1988) Inhibition of dunning tumor growth by melatonin. J Urol 139:1099-1102
52. Sze SF, Ng TB, Liu WK (1993) Anti-proliferative effect of pineal indoles on cultured tumor cell lines. J Pineal Res 14:27-33
53. Ying SW, Niles LP, Crocker C (1993) Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin. Eur J Pharmacol 246:89-96
54. Petranka J, Baldwin WS, Bierman J, et al. (1999) The oncostatic action of melatonin in an ovarian carcinoma cell line. J Pineal Res 26:129-136
55. Shiu SY, Li L, Xu JN, et al. (1999) Melatonin-induced inhibition of proliferation and G1/S cell cycle transition delay of human choriocarcinoma JAr cells: possible involvement of MT2 (MEL1B) receptor. J Pineal Res 27:183-192
56. Kanishi Y, Kobayashi Y, Noda S, et al. (2000) Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines. J Pineal Res 28:227-233
57. Tamarkin L, Cohen M, Roselle D, et al. (1981) Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Cancer Res 41:4432-4436
58. Musatov SA, Anisimov VN, Andre V, et al. (1999) Effects of melatonin on N-nitroso-N-methylurea-induced carcinogenesis in rats and mutagenesis in vitro (Ames test and COMET assay). Cancer Lett 138:37-44
59. Anisimov VN, Popovich IG, Zabezhinski MA (1997) Melatonin and colon carcinogenesis: I. Inhibitory effect of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats. Carcinogenesis 18:1549-1553
60. Anisimov VN, Kvetnoy IM, Chumakova NK, et al. (1999) Melatonin and colon carcinogenesis. Exp Toxicol Pathol 51:47-52
61. Cini G, Coronnello M, Mini E, et al. (1988) Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat. Cancer Lett 125:51-59
62. Mocchegiani E, Perissin L, Santarelli L, et al. (1999) Melatonin administration in tumor-bearing mice (intact and pinealectomized) in relation to stress, zinc, thymulin and IL-2. Int J Immunopharmacol 21:27-46
63. Subramanian A, Kothari L (1991) Melatonin, a suppressor of spontaneous murine mammary tumors. J Pineal Res 10(3):136-140
64. Jochle W (1964) Trends in photophysiologic concepts. Ann N Y Acad Sci 117:88-104
65. Shah PN, Mhatre MC, Kothari LS (1984) Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. Cancer Res 44:3403-3407
66. Blask DE, Sauer LA, Dauchy R, et al. (1999) New actions of melatonin on tumor metabolism and growth. Biol Signals Recept 8:49-55
67. Blask DE, Dauchy RT, Sauer LA, et al. (2002) Light during darkness, melatonin suppression and cancer progression. Neuroendocrinol Lett 23:52-56
68. Dauchy RT, Sauer LA, Blask DE, et al. (1997) Light contamination during the dark phase in "photoperiodically controlled" animal rooms: effect on tumor growth and metabolism in rats. Lab Anim Sci 47:511-518
69. Dauchy RT, Blask DE, Sauer LA, et al. (1999) Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Cancer Lett 144:131-136
70. Hahn RA (1991) Profound bilateral blindness and the incidence of breast cancer. Epidemiology 2:208-210
71. Feychting M, Osterlund B, Ahlbom A (1998) Reduced cancer incidence among the blind. Epidemiology 9:490-494
72. Pukkala E, Verkasalo PK, Ojamo M, et al. (1999) Visual impairment and cancer: a population-based cohort study in Finland. Cancer Causes Control 10:13-20
73. Verkasalo PK, Pukkala E, Stevens RG, et al. (1999) Inverse association between breast cancer incidence and degree of visual impairment in Finland. Br J Cancer 80:1459-1460
74. Kliukiene J, Tynes T, Andersen A (2001) Risk of breast cancer among Norwegian women with visual impairment. Br J Cancer 84:397-399
75. Reppert SM, Weaver DR (2001) Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 63:647-676
76. Katzenberg D, Young T, Finn L, et al. (1998) A CLOCK polymorphism associated with human diurnal preference. Sleep 21:569-576
77. Johansson C, Willeit M, Smedh C, et al. (2003) Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology 28(4):734-739
78. Archer SN, Robilliard DL, Skene DJ, et al. (2003) A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 26:413-415
79. Ebisawa T, Uchiyama M, Kajimura N, et al. (2001) Association of structural polymorphisms in the human periods gene with delayed sleep phase syndrome. EMBO Rep 2:342-346
80. Parry BL, Newton RP (2001) Chronobiological basis of female-specific mood disorders. Neuropsychopharmacology 25:S102-S108
81. Zhu Y, Brown HN, Zhang Y, et al. (2005) Periods structural variation: a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers Prev 14:268-270
82. Fu L, Pelicano H, Liu J, et al. (2002) The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111:41-50
83. Davis S, Kaune WT, Mirick D, Chen C, Stevens RG. (2001) Residential Magnetic Fields, Light-at-Night, and Nocturnal Urinary 6-sulphatoxymelatonin in Women. Am J Epidemiol 154:591-600